The Company
Indian Wells Medical, Inc. was founded to develop medical devices that improve the outcomes of cardiology and electrophysiology procedures. The Company focuses on devices with short development and regulatory cycles. Cardiologists and electrophysiologists work in a field that demands ever-improved results. The Company believes that it can meet this demand by providing its customers with innovative devices that offer improved performance, ease of use, and reduced healthcare costs.
The Market
The cardiology and electrophysiology marketplaces are large and growing. Procedures in these markets include transcatheter cardiac valve replacement, percutaneous cardiac valve repair, arterial stent-graft placement, left atrial appendage closure, stent placement, treatment of atrial fibrillation, transcatheter coronary artery repair, cardiac rhythm management, and the like.
More than 2 million Americans have arrhythmias originating in the left atrium that could be treated endovascularly; 226,000 electrophysiology studies and 135,000 catheter ablations procedures are performed in the US each year.
The Product: Steerable Transseptal Needle
The Company has developed its Steerable Transseptal Needle (STSN) capable of being inserted through a transseptal introducer. The distal curve of the Steerable Transseptal Needle can be controllably adjusted, under fluoroscopy or echocardiography, to facilitate targeting the fossa ovalis.